Your browser doesn't support javascript.
loading
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomas.
Vannata, Barbara; Vanazzi, Anna; Negri, Mara; Liptrott, Sarah Jayne; Bartosek, Anna Amalia; Miani, Monica; Di Sanzo, Alessandro; Cavalli, Franco; Zucca, Emanuele; Stathis, Anastasios.
Afiliación
  • Vannata B; Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
  • Vanazzi A; Division of Clinical Hemato-Oncology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
  • Negri M; Division of Clinical Hemato-Oncology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
  • Liptrott SJ; Division of Clinical Hemato-Oncology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
  • Bartosek AA; Nerviano Medical Sciences S.r.l, Nerviano, Milan, Italy.
  • Miani M; Nerviano Medical Sciences S.r.l, Nerviano, Milan, Italy.
  • Di Sanzo A; Nerviano Medical Sciences S.r.l, Nerviano, Milan, Italy.
  • Cavalli F; Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
  • Zucca E; Faculty of Biomedical Sciences, Institute of Oncology Research (IOR), Bellinzona, Switzerland.
  • Stathis A; Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
Hematol Oncol ; 39(1): 60-65, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33103778
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B de la Zona Marginal Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2021 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B de la Zona Marginal Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2021 Tipo del documento: Article País de afiliación: Suiza